Tobramycin
Tobramycin

Tobramycin

Gram Negative (2022)

% of Isolates Susceptible

98% n = 364

Cystic fibrosis isolates (n=28): 93%

96% n = 186

Tobramycin (2023): S=95%

95% n = 866

Tobramycin (2023): S=87%

91% n = 78

Tobramycin (2023): S=85%

85% n = 92
79% n = 37

Notes

If there are less than 12 isolates per year of a particular organism, the antibiogram for that organism is not included

Infection control screens to detect colonization with resistant organisms are not included in the analysis, e.g. MRSA, VRE

Statistical validity of % susceptibility determination for organisms with fewer than 30 isolates reported is limited; please take this into consideration when interpreting the reported results